Last reviewed · How we verify
MMR followed by YF — Competitive Intelligence Brief
marketed
Live attenuated viral vaccine combination
Immunology / Infectious Disease
Biologic
Live · refreshed every 30 min
Target snapshot
MMR followed by YF (MMR followed by YF) — Alba Maria Ropero. MMR vaccine primes immune response against measles, mumps, and rubella; yellow fever vaccine then boosts immunity against yellow fever virus.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| MMR followed by YF TARGET | MMR followed by YF | Alba Maria Ropero | marketed | Live attenuated viral vaccine combination |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Live attenuated viral vaccine combination class)
- Alba Maria Ropero · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- MMR followed by YF CI watch — RSS
- MMR followed by YF CI watch — Atom
- MMR followed by YF CI watch — JSON
- MMR followed by YF alone — RSS
- Whole Live attenuated viral vaccine combination class — RSS
Cite this brief
Drug Landscape (2026). MMR followed by YF — Competitive Intelligence Brief. https://druglandscape.com/ci/mmr-followed-by-yf. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab